Podcast

Commercialization Readiness

Navigating Europe's complex commercialization landscape: essential steps for non-EU pharmaceutical companies

Pharmaceutical companies new to the EU market must navigate complex and varying commercialization requirements. The podcast highlights key steps for commercialization readiness in Europe, focusing on the challenges non-EU companies face, including supply chain logistics and regulatory complexities. Early planning, strategic partnerships, and understanding local regulations are essential for successful product launches in diverse European markets.

Subscribe to PharmaLex talks via one of the services below and get the newest episodes instantly.

Related resources

Newsletter

HTA Quarterly Summer 2026

Article

Rare diseases and orphan drugs: Assessing the PV implications

Article

AI-assisted quality assessment in HEOR: What works, what doesn’t, and how to apply GenAI responsibly